Summary
Colgate-Palmolive Company (CL) announced on June 1, 2004, the completion of its acquisition of GABA Holding AG ("GABA"), a privately-owned European oral care company. The transaction, valued at approximately US$841 million (1,051 million Swiss francs) in cash, was executed through a wholly owned subsidiary, GABA Holdings Delaware, LLC. The acquisition includes GABA's assets, primarily located in Switzerland, Germany, and Austria, encompassing trademarks, intellectual property, receivables, inventory, and physical property used in its oral care business. This strategic acquisition strengthens Colgate-Palmolive's presence in the European oral care market, adding a European-based business to its portfolio. The purchase price is subject to adjustment based on GABA's audited financial statements as of the closing date. The acquisition was financed through the issuance of commercial paper, indicating a reliance on short-term debt to fund the transaction.
Key Highlights
- 1Colgate-Palmolive acquired GABA Holding AG, a European oral care company, for approximately $841 million in cash.
- 2The acquisition was completed on June 1, 2004.
- 3GABA's operations are primarily located in Switzerland, Germany, and Austria.
- 4The acquired assets include valuable trademarks and intellectual property within the oral care sector.
- 5The purchase price is subject to post-closing adjustments based on audited financials.
- 6Financing for the acquisition was provided through the issuance of commercial paper.
- 7The deal was executed through a wholly-owned subsidiary, GABA Holdings Delaware, LLC.